Allakos Company Leadership
| ALLK Stock | USD 1.02 0.03 2.86% |
About 88 percent of Allakos' insiders are activelly selling. The analysis of the overall insider sentiment regarding Allakos suggests that many insiders are panicking. Allakos employs about 131 people. The company is managed by 22 executives with a total tenure of roughly 87 years, averaging almost 3.0 years of service per executive, having 5.95 employees per reported executive.
| Robert Alexander CEO CEO, Director |
| Daniel Janney Chairman Chairman of the Board |
Allakos' Insider Buying Vs Selling
12
Selling | Buying |
Latest Trades
| 2022-09-21 | Paul Edward Walker | Acquired 3984000 @ 5.02 | View | ||
| 2021-09-28 | Steven P James | Disposed 4000 @ 108.12 | View | ||
| 2021-06-14 | Adam Tomasi | Disposed 20000 @ 91.62 | View | ||
| 2021-06-07 | Adam Tomasi | Disposed 2487 @ 92.03 | View | ||
| 2021-06-04 | Robert Alexander | Disposed 18113 @ 89.64 | View | ||
| 2021-06-02 | Robert Alexander | Disposed 14517 @ 94.55 | View | ||
| 2021-05-18 | Robert Alexander | Disposed 14517 @ 102.32 | View | ||
| 2021-05-11 | Adam Tomasi | Disposed 20000 @ 97.79 | View |
Monitoring Allakos' insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Allakos |
Allakos Management Team Effectiveness
The company has return on total asset (ROA) of (0.389) % which means that it has lost $0.389 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.775) %, meaning that it created substantial loss on money invested by shareholders. Allakos' management efficiency ratios could be used to measure how well Allakos manages its routine affairs as well as how well it operates its assets and liabilities. The value of Return On Tangible Assets is estimated to slide to -0.8. The value of Return On Capital Employed is expected to slide to -0.99. At this time, Allakos' Liabilities And Stockholders Equity is quite stable compared to the past year. Non Current Liabilities Other is expected to rise to about 55.5 M this year, although the value of Total Current Liabilities will most likely fall to about 21 M.The value of Common Stock Shares Outstanding is expected to slide to about 52.9 M. Net Loss is expected to rise to about (273.6 M) this year
Allakos Workforce Comparison
Allakos is rated second in number of employees category among related companies. The total workforce of Health Care industry is presently estimated at about 691. Allakos retains roughly 131 in number of employees claiming about 19% of equities under Health Care industry.
Allakos Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Allakos insiders, such as employees or executives, is commonly permitted as long as it does not rely on Allakos' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Allakos insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Robert Alexander few days ago Disposition of 9143 shares by Robert Alexander of Allakos at 6.4 subject to Rule 16b-3 | ||
Radford Harlan Baird over a month ago Disposition of 32142 shares by Radford Harlan Baird of Allakos at 1.35 subject to Rule 16b-3 | ||
Adam Tomasi over a month ago Disposition of 47392 shares by Adam Tomasi of Allakos at 1.44 subject to Rule 16b-3 | ||
Robert Alexander over a month ago Disposition of 70910 shares by Robert Alexander of Allakos at 1.48 subject to Rule 16b-3 | ||
Adam Tomasi over two months ago Acquisition by Adam Tomasi of 1200000 shares of Allakos subject to Rule 16b-3 | ||
Adam Tomasi over two months ago Acquisition by Adam Tomasi of 1200000 shares of Allakos at 1.25 subject to Rule 16b-3 | ||
Adam Tomasi over six months ago Payment of 18219 shares by Adam Tomasi of Allakos subject to Rule 16b-3 | ||
Sutherland Everett Rand over six months ago Acquisition by Sutherland Everett Rand of 154786 shares of Allakos subject to Rule 16b-3 |
Allakos Notable Stakeholders
An Allakos stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Allakos often face trade-offs trying to please all of them. Allakos' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Allakos' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Robert Alexander | CEO, Director | Profile | |
| Daniel Janney | Chairman of the Board | Profile | |
| Ruby Casareno | Vice President - Manufacturing | Profile | |
| Nenad Tomasevic | Co-Founder, Vice President - Research | Profile | |
| Adam Tomasi | President | Profile | |
| Sally Bolmer | Vice President - Regulatory Affairs and Drug Development | Profile | |
| Christopher Bebbington | President Founder, Director | Profile | |
| Leo Redmond | CFO | Profile | |
| Steven James | Independent Director | Profile | |
| Paul Walker | Independent Director | Profile | |
| Robert Andreatta | Independent Director | Profile | |
| John McKearn | Director | Profile | |
| Tim Varacek | Chief Commercial Officer | Profile | |
| Mary Cromwell | Chief Officer | Profile | |
| Simon Greenwood | Chief Business Officer | Profile | |
| Alan Chang | Director Analytics | Profile | |
| Brad Youngblood | Head Research | Profile | |
| Mark Asbury | Chief Legal Officer and General Counsel | Profile | |
| Craig MD | Chief Officer | Profile | |
| Henrik Rasmussen | Chief Medical Officer | Profile | |
| Baird III | Chief Officer | Profile | |
| MPH MD | Chief Officer | Profile |
About Allakos Management Performance
The success or failure of an entity such as Allakos often depends on how effective the management is. Allakos management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Allakos management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Allakos management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.76) | (0.80) | |
| Return On Capital Employed | (0.95) | (0.99) | |
| Return On Assets | (0.76) | (0.80) | |
| Return On Equity | (1.10) | (1.05) |
The data published in Allakos' official financial statements usually reflect Allakos' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Allakos. For example, before you start analyzing numbers published by Allakos accountants, it's critical to develop an understanding of what Allakos' liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of Allakos' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Allakos' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Allakos' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Allakos. Please utilize our Beneish M Score to check the likelihood of Allakos' management manipulating its earnings.
Allakos Workforce Analysis
Traditionally, organizations such as Allakos use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Allakos within its industry.Allakos Manpower Efficiency
Return on Allakos Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 1.4M | |
| Net Loss Per Executive | 8.4M | |
| Working Capital Per Employee | 1.1M | |
| Working Capital Per Executive | 6.5M |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Allakos. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. For more information on how to buy Allakos Stock please use our How to buy in Allakos Stock guide.You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Complementary Tools for Allakos Stock analysis
When running Allakos' price analysis, check to measure Allakos' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Allakos is operating at the current time. Most of Allakos' value examination focuses on studying past and present price action to predict the probability of Allakos' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Allakos' price. Additionally, you may evaluate how the addition of Allakos to your portfolios can decrease your overall portfolio volatility.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| CEOs Directory Screen CEOs from public companies around the world |
Is Allakos' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Allakos. If investors know Allakos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Allakos listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.14) | Return On Assets (0.39) | Return On Equity (0.78) |
The market value of Allakos is measured differently than its book value, which is the value of Allakos that is recorded on the company's balance sheet. Investors also form their own opinion of Allakos' value that differs from its market value or its book value, called intrinsic value, which is Allakos' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Allakos' market value can be influenced by many factors that don't directly affect Allakos' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Allakos' value and its price as these two are different measures arrived at by different means. Investors typically determine if Allakos is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Allakos' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.